Article
- The EMBO Journal (2005) 24, 1810 - 1820
- doi:10.1038/sj.emboj.7600667
Published online: 5 May 2005
Subject Categories:
Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction
Kei Sakamoto1, Afshan McCarthy2, Darrin Smith2, Kevin A Green3, D Grahame Hardie3, Alan Ashworth2 and Dario R Alessi1
- MRC Protein Phosphorylation Unit, University of Dundee, Dundee, UK
- The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
- Division of Molecular Physiology, School of Life Sciences, University of Dundee, Dundee, UK
Correspondence to:
Kei Sakamoto, MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK. Tel.: +44 1382 34 4241; Fax: +44 1382 223 778; E-mail: k.sakamoto@dundee.ac.uk
Received 22 December 2004; Accepted 31 March 2005
Abstract
Recent studies indicate that the LKB1 tumour suppressor protein kinase is the major 'upstream' activator of the energy sensor AMP-activated protein kinase (AMPK). We have used mice in which LKB1 is expressed at only 
10% of the normal levels in muscle and most other tissues, or that lack LKB1 entirely in skeletal muscle. Muscle expressing only 10% of the normal level of LKB1 had significantly reduced phosphorylation and activation of AMPK
2. In LKB1-lacking muscle, the basal activity of the AMPK2 isoform was greatly reduced and was not increased by the AMP-mimetic agent, 5-aminoimidazole-4-carboxamide riboside (AICAR), by the antidiabetic drug phenformin, or by muscle contraction. Moreover, phosphorylation of acetyl CoA carboxylase-2, a downstream target of AMPK, was profoundly reduced. Glucose uptake stimulated by AICAR or muscle contraction, but not by insulin, was inhibited in the absence of LKB1. Contraction increased the AMP:ATP ratio to a greater extent in LKB1-deficient muscles than in LKB1-expressing muscles. These studies establish the importance of LKB1 in regulating AMPK activity and cellular energy levels in response to contraction and phenformin.
Keywords:
- AMP-activated protein kinase,
- glucose transport,
- LKB1,
- phenformin,
- skeletal muscle
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Small molecules can have big effects on endurance
Nature Chemical Biology News and Views (01 Oct 2008)
Cellular energy sensor balances the scales
Nature Medicine News and Views (01 Jul 2004)
RESEARCH
Oncogene Original Article
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
Nature Article (20 Oct 2005)
